资讯

近日,上海迈英诺医药科技有限公司(Shanghai Medinno Pharmaceutical Technology Co.,Ltd.)(以下称“上海迈英诺”)宣布其自主研发的1类新药MDI-1228_mesylate 滴 ...
eribulin mesylate)。在中国,被诊断为乳腺癌的女性人数近年来有所增加,乳腺癌已成为中国女性诊断高发癌症之一,2018年新增乳腺癌病例37万例 ...
相关研究近期发表在medRxiv预印本服务器上,论文标题为“A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 ...
Imatinib mesylate (IM) is a tyrosine kinase inhibitor, which inhibits phosphorylation of downstream proteins involved in BCR-ABL signal transduction. It has proved beneficial in treating patients ...
Eribulin mesylate is a synthetic macrocyclic ketone analogue of Halichondrin B that has demonstrated high antitumor activity in preclinical and clinical settings. This phase I study aimed to ...
The tyrosine kinase inhibitor imatinib mesylate specifically inhibits ABL, PDGFR, and KIT kinases and has impressive clinical efficacy in BCR-ABL–positive chronic myeloid leukemia. In all four ...
56,57 Comparison of Hydroxyurea, Interferon Alfa, and Imatinib Mesylate for the Treatment of CML. Blast-phase CML is resistant to both hydroxyurea and interferon alfa. Multiagent chemotherapy ...
Effect of Complete Remission and Responses Less Than Complete Remission on Survival in Acute Myeloid Leukemia: A Combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D.
Recently, a new nontaxane agent, eribulin mesylate, was approved for the treatment of metastatic breast cancer in patients who have received at least two prior chemotherapeutic agents. Eribulin is ...
Histopathologic and immunohistochemical findings of skin rash to HER1 and HER1/2 inhibitors during anticancer therapy. Background: The nontaxane microtubule dynamics inhibitor, eribulin mesylate ...
Learn everything you need to know about Garenoxacin Mesylate-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects ...
Details concerning the Phentolamine Mesylate medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments ...